Paragon 28, Inc. (NYSE:FNA) Q1 2023 Earnings Conference Call May 4, 2023 4:30 PM ET Company Participants Matt Brinckman - Senior Vice President, Strategy and Investor Relations Albert DaCosta - Chairman and Chief Executive Officer Stephen Deitsch - Chief Financial Officer Conference Call Participants Dave Turkaly - JMP Securities Caitlin Cronin - Canaccord George Sellers - Stephens, Inc. Craig Bijou - Bank of America Mike Mattson - Needham Company Neil Chatterji - B. Riley Samantha Kurtz - Piper Sandler Ope ...

净收入和亏损 - 公司在2023年第一季度的净收入从4140万美元增长到5200万美元，增长了26%[47] - 2023年第一季度的净亏损从920万美元降至910万美元[47] 资金状况 - 公司于2023年3月31日和2022年12月31日分别拥有现金8590万美元和3850万美元[48] - 公司通过公开发行筹集的净收益约为6850万美元[49] 发展计划 - 公司计划继续投资Smart 28以改善足踝患者的结果[50] - 公司致力于在美国和国际市场扩大商业版图[52] 预期增长 - 公司预计净收入将随着销售领域的扩张、新增客户和现有客户对产品的利用增加而增长[61] - 公司预计成本销售将随着销售量的增加而增加[62] 费用增加 - 研发费用增加了1,276万美元，增幅为22%，主要是由于新增投资于新产品开发、临床研究和质量管理系统[66] - 销售、一般和行政费用增加了6,578万美元，增幅为18%，主要是由于投资于销售和营销、包括在美国和国际市场扩大商业团队[66] 净收入增长 - 净收入增加了10,665万美元，增幅为26%，主要是由于销售团队扩张和新产品推出[67] 现金流 - 2023年第一季度，公司经营活动净现金流为负14,060万美元，较去年同期下降48%[72] - 2023年第一季度，公司投资活动净现金流为负7,552万美元，较去年同期下降82%[72] - 2023年第一季度，公司融资活动净现金流为69,367万美元，较去年同期增长95%[72] - 2023年第一季度，公司现金净增加为47,415万美元[72] 投资和融资活动 - 2023年第一季度，公司投资活动主要用于手术器械购买和其他固定资产购买，金额为7.6万美元[73] - 2023年第一季度，公司融资活动主要来源于发行普通股融资，净额为69.4万美元[74] 财务报表 - 公司管理层对财务报表进行了基于美国通用会计准则的估计和假设，强调这些估计是基于历史经验和其他因素的[75] - 公司的投资活动主要目标是保值和提供流动性，不会对财务报表产生显著影响[77] - 公司主要以美元进行业务，外币交易不会对业绩、财务状况或现金流产生重大影响[78] - 公司管理层认为截至本季度末，披露控制和程序有效性水平是合理的[79]

Paragon 28, Inc. (NYSE:FNA) Q4 2022 Earnings Conference Call March 2, 2023 4:30 PM ET Company Participants Matt Brinckman - Investor Relations Albert DaCosta - Chairman and Chief Executive Officer Stephen Deitsch - Chief Financial Officer Conference Call Participants Kyle Rose - Canaccord Craig Bijou - Bank of America Mike Matson - Needham David Turkaly - JMP Securities Neil Chatterji - B. Riley Operator Good afternoon, and welcome to the Paragon 28's Fourth Quarter 2022 Earnings Conference Call. Currently ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-40902 Paragon 28, Inc. (Exact name of Registrant as specified in its Charter) Delaware 27-3170186 (State or other jurisdiction of (I. ...

Paragon 28, Inc. (NYSE:FNA) Q3 2022 Earnings Conference Call November 10, 2022 4:30 PM ET Company Participants Matt Brinckman - IR Albert DaCosta - Co Founder, President and Chief Executive Officer Stephen Deitsch - Chief Financial Officer Conference Call Participants Kyle Rose - Canaccord Mike Matson - Needham & Company Craig Bijou - Bank of America Dave Turkaly - JMP Securities Operator Good afternoon, and welcome to Paragon 28 Third Quarter 2022 Earnings Conference Call. [Operator Instructions] As a remi ...

Paragon 28, Inc. (NYSE:FNA) Q2 2022 Earnings Conference Call August 3, 2022 4:30 PM ET Company Participants Matt Bacso - Gilmartin Group Albert DaCosta - Co Founder, President and Chief Executive Officer Stephen Deitsch - Chief Financial Officer Conference Call Participants Craig Bijou - Bank of America Kyle Rose - Canaccord Mike Mattson - Needham David Turkaly - JMP Securities Operator Good afternoon and welcome to the Paragon 28Â's Second Quarter 2022 Earnings Conference Call. [Operator Instructions] As a ...

Paragon 28, Inc. (NYSE:FNA) Q1 2022 Earnings Conference Call May 9, 2022 4:30 PM ET Company Participants Matt Bacso - Gilmartin Group Albert DaCosta - Co Founder, President and Chief Executive Officer Stephen Deitsch - Chief Financial Officer Conference Call Participants Matthew O'Brien - Piper Sandler David Turkaly - JMP Securities Mike Mattson - Needham & Company Operator Good afternoon and welcome to the Paragon 28Â's First Quarter 2022 Earnings Conference Call. [Operator Instructions] As a reminder, thi ...

Foot & Ankle Specialists March 2022 Disclaimer Except for the historical information contained herein, the matters set forth in this presentation are forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, including, but not limited to: Paragon 28, Inc.'s (the "Company," "Paragon 28," "we," or "our") potential to shape a better future for foot and ankle patients and its estimated 2022 and first quarter 2022 net revenues. You are ...

Paragon 28, Inc. (NYSE:FNA) Q4 2021 Earnings Conference Call March 8, 2022 4:30 PM ET Company Participants Matt Bacso - Gilmartin Group Albert DaCosta - Chairman and CEO Stephen Deitsch - Chief Financial Officer Conference Call Participants Matthew O'Brien - Piper Sandler Craig Bijou - Bank of America Kyle Rhodes - Cannacord David Turkaly - JMP Securities Mike Mattson - Needham & Company Operator Good afternoon and welcome to the Paragon 28 Fourth Quarter and Full Year 2021 Earnings Conference Call. Current ...